BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$159.60
-1.46 (-0.91%)
▼
5d:
-2.21%
30d:
+4.07%
90d:
+16.24%
HOLD
MODERATE Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$75.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$46.58
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $159.60, which is considered fair relative to its 30-day fair value range of $153.61 to $167.17. From a valuation perspective, the stock is trading at a discount (Forward PE: 75.2) compared to its historical average (175.2). Remarkably, the market is currently pricing in an annual earnings decline of 24.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is showing sideways momentum. The price is currently testing key support at $159.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $214.00 (+32.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLTE is showing sideways momentum. The price is currently testing key support at $159.00. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $214.00 (+32.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$153.61 -
$167.17
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 32.9% below Wall St target ($214.00)
- NEUTRAL: Bottoming setup forming (44/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$153.61 -
$167.17
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$159.00
Resistance Level
$181.56
Current Trend
Sideways
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
75.21
Wall Street Target
$214.00
(+32.9%)
Valuation Discount vs History
-24.6% cheaper
PE vs Historical
75.2 vs 175.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.6%
(market-implied from PE analysis)
1-Year Target
$144.95
(-10%)
2-Year Target
$130.46
(-19%)
3-Year Target
$117.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 75→175)
$273.50
(+70%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 75.2 to 175.2
Stabilization Target:
$375.17
(+132.9%)
PE Expansion Potential:
+132.9%
Share & Embed Analysis
Last updated: August 24, 2026 10:04 AM ET
Data refreshes hourly during market hours. Next update: 11:04 AM
Data refreshes hourly during market hours. Next update: 11:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-22
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 42 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$285 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$108 | 52 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
